<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02717637</url>
  </required_header>
  <id_info>
    <org_study_id>2014/1781</org_study_id>
    <nct_id>NCT02717637</nct_id>
  </id_info>
  <brief_title>Oxycodone in Serum After Postoperative Oral Oxycodone in Caesarean Sections Under Spinal Anesthesia</brief_title>
  <official_title>Gastrointestinal Uptake of Oxycodone After Caesarean Section in Spinal Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Akershus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Akershus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      All patients undergoing an elective caesarean section under spinal anesthesia will, according
      to the hospital routines, receive 10 mg oxycodone slow-release tablet when arriving at our
      postoperative care unit (PACU). Blood samples will be taken at 0 hour, 1 hour, 2 and 6 hours
      after administration in order to investigate bioavailability.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After written informed consent, blood samples will be taken before administration, after 1
      hour, 2 hours and 6 hours. Need of rescue analgesia (morphine iv) and level of pain, as well
      as side effects will be registered
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>level of oxycodone in serum</measure>
    <time_frame>1 hour after administration</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>level of oxycodone in serum</measure>
    <time_frame>2 hours after administration</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>level of oxycodone in serum</measure>
    <time_frame>6 hours after administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>level of pain</measure>
    <time_frame>0, 1, 2, and 6 hours after administration</time_frame>
    <description>NRS scale 0-10</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Side effects</measure>
    <time_frame>1,2 and 6 hourd after administration</time_frame>
    <description>nausea and vomiting, other side effects</description>
  </other_outcome>
  <enrollment type="Actual">50</enrollment>
  <condition>Analgesic Adverse Reaction</condition>
  <condition>Cesarean Delivery Affecting Newborn</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum from blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women with single fetus in cephalated position admitted for elective caesarean section in
        spinal anesthesia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: Healthy women &gt; 18 years old, with one healthy fetus scheduled for a
        elective caesarean section in spinal anesthesia, read and signed informed consent

        Exclusion Criteria:

          -  Known intolerability to oxycodone. Previous use of opioids. Hight &lt; 150 cm,
             preconceptual BMI &gt; 35. ASA &gt; 2.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vegard Dahl, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of anesthesia dept</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Akershus University Hospital</name>
      <address>
        <city>Nordbyhagen</city>
        <state>Akershus</state>
        <zip>1478</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2016</study_first_submitted>
  <study_first_submitted_qc>March 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2016</study_first_posted>
  <last_update_submitted>January 11, 2018</last_update_submitted>
  <last_update_submitted_qc>January 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Akershus</investigator_affiliation>
    <investigator_full_name>Vegard Dahl</investigator_full_name>
    <investigator_title>Professor 2</investigator_title>
  </responsible_party>
  <keyword>oxycodone, caesarean, spinal anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

